GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 3351 - 3375 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID Arbitrary Fluorescence Units (AFU) ▼
IgG Patient 3 11 mild
G14844CX
45
IgG Patient 3 11 mild
G18057VI
45
IgG Patient 3 11 mild
G24432YB
45
IgG Patient 3 11 mild
G58969RU
45
IgG Patient 3 11 mild
G90223GH
45
IgG Patient 3 4 mild
G58969RU
45
IgG Patient 1 22 moderate
G36374CE
44
IgG Patient 1 22 moderate
G49916XD
44
IgG Patient 1 22 moderate
G92022ML
44
IgM Patient 1 10 moderate
G10789DJ
44
IgM Patient 1 10 moderate
G19868AX
44
IgM Patient 1 10 moderate
G21460SG
44
IgM Patient 1 10 moderate
G25473LQ
44
IgM Patient 1 10 moderate
G40696TO
44
IgM Patient 1 10 moderate
G47566FL
44
IgM Patient 1 10 moderate
G51872EK
44
IgG Patient 2 15 mild
G78074HX
44
IgG Patient 2 15 mild
G82779CI
44
IgG Patient 2 24 mild
G39023AU
44
IgM Patient 2 3 mild
G12200GB
44
IgG Patient 3 -180 mild
G00054MO
44
IgG Patient 3 -180 mild
G02670IJ
44
IgG Patient 3 -180 mild
G09609EN
44
IgG Patient 3 -180 mild
G15209MJ
44
IgG Patient 3 -180 mild
G22768VO
44

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024